Charles River Laboratories International (CRL)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Charles River Laboratories International (CRL)
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Key Insights
Critical company metrics and information
Share Price
$199.97Market Cap
$10.23 BillionTotal Outstanding Shares
51.14 Million SharesTotal Employees
21,400Dividend
No dividendIPO Date
June 23, 2000SIC Description
Services-commercial Physical & Biological ResearchHomepage
https://www.criver.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
September 29, 2023 to September 28, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $37.33 Million |
Net Cash Flow From Investing Activities | $-407.35 Million |
Net Cash Flow | $46.02 Million |
Net Cash Flow From Operating Activities | $796.16 Million |
Net Cash Flow From Financing Activities | $-351.48 Million |
Net Cash Flow From Operating Activities, Continuing | $796.16 Million |
Net Cash Flow From Investing Activities, Continuing | $-407.35 Million |
Exchange Gains/Losses | $8.70 Million |
Net Cash Flow From Financing Activities, Continuing | $-351.48 Million |
Income Statement
September 29, 2023 to September 28, 2024
Metric | Value |
---|---|
Net Income/Loss | $427.99 Million |
Benefits Costs and Expenses | $3.55 Billion |
Revenues | $4.06 Billion |
Operating Income/Loss | $527.96 Million |
Preferred Stock Dividends And Other Adjustments | $10.70 Million |
Other Operating Expenses | $2.76 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $4.21 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $10.70 Million |
Costs And Expenses | $3.57 Billion |
Selling, General, and Administrative Expenses | $752.44 Million |
Income/Loss From Continuing Operations Before Tax | $512.79 Million |
Diluted Average Shares | $103.35 Million |
Income/Loss From Continuing Operations After Tax | $427.99 Million |
Basic Average Shares | $154.41 Million |
Net Income/Loss Attributable To Parent | $423.78 Million |
Net Income/Loss Available To Common Stockholders, Basic | $413.08 Million |
Diluted Earnings Per Share | $8.01 |
Income Tax Expense/Benefit | $90.62 Million |
Operating Expenses | $3.51 Billion |
Basic Earnings Per Share | $8.04 |
Balance Sheet
September 29, 2023 to September 28, 2024
Metric | Value |
---|---|
Redeemable Noncontrolling Interest | $40.59 Million |
Other Current Liabilities | $665.18 Million |
Wages | $211.08 Million |
Noncurrent Liabilities | $3.16 Billion |
Current Assets | $1.49 Billion |
Liabilities | $4.18 Billion |
Other Current Assets | $1.07 Billion |
Assets | $8.00 Billion |
Equity Attributable To Parent | $3.78 Billion |
Liabilities And Equity | $8.00 Billion |
Inventory | $336.20 Million |
Noncurrent Assets | $6.51 Billion |
Temporary Equity | $40.59 Million |
Equity Attributable To Noncontrolling Interest | $4.85 Million |
Equity | $3.79 Billion |
Prepaid Expenses | $92.63 Million |
Current Liabilities | $1.01 Billion |
Accounts Payable | $135.96 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.